Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by theteddyfactoron Jun 22, 2022 12:31pm
218 Views
Post# 34774398

News

NewsWhen share holders after a news release , shares drop. Raises red flags , but in penny stocks they seem to hold back infpe or pending what can be said. It is at this time I think Howard and or his IR team make suggestions good is just about to happen. 

Since the last news , I diluted 50% of my holdings nowing that Sirona ability to produce eye cathing news created nothing real of value that suggest stability. Having one week with positive Volume to whom ever was given credit or why?

Give me a few weeks of electicity with the volume, but for now 50% of my investment remains for a few weeks and  after two weeks run from mediocrity share movement  and management .

I do feel good with the Dr. Wolfgang Bieber, but just being a an advisor makes it just cosmetics. Why not add him to management or board? His  Bio makes him shine. Let him take the roll of CEO or VP. Cosemtics attention will no longer work given many on this board have seen cosmetic news. 

I hope Biorun who said Monday is to early. I will give two weeks of my time. I pray he/she is correct.
<< Previous
Bullboard Posts
Next >>